vs
Side-by-side financial comparison of Citius Pharmaceuticals, Inc. (CTXR) and Solid Power, Inc. (SLDP). Click either name above to swap in a different company.
Citius Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($3.9M vs $3.6M, roughly 1.1× Solid Power, Inc.).
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing innovative prescription therapies addressing unmet medical needs across critical care, oncology, anti-infective treatment, and supportive care segments, primarily serving the U.S. healthcare market.
Solid Energy was the largest coal mining company in New Zealand and is a state owned enterprise of the New Zealand Government.
CTXR vs SLDP — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $3.6M |
| Net Profit | $-9.4M | — |
| Gross Margin | 80.0% | — |
| Operating Margin | -228.7% | -730.1% |
| Net Margin | -238.2% | — |
| Revenue YoY | — | -18.6% |
| Net Profit YoY | 8.6% | — |
| EPS (diluted) | $-0.38 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $3.6M | ||
| Q3 25 | — | $3.7M | ||
| Q2 25 | — | $6.5M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $4.7M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | — | $6.0M |
| Q4 25 | $-9.4M | — | ||
| Q3 25 | — | $-25.9M | ||
| Q2 25 | — | $-25.3M | ||
| Q1 25 | — | $-15.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-22.4M | ||
| Q2 24 | — | $-22.3M | ||
| Q1 24 | — | $-21.2M |
| Q4 25 | 80.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -228.7% | -730.1% | ||
| Q3 25 | — | -654.4% | ||
| Q2 25 | — | -398.9% | ||
| Q1 25 | — | -399.4% | ||
| Q4 24 | — | -561.1% | ||
| Q3 24 | — | -593.2% | ||
| Q2 24 | — | -530.8% | ||
| Q1 24 | — | -433.1% |
| Q4 25 | -238.2% | — | ||
| Q3 25 | — | -693.1% | ||
| Q2 25 | — | -390.7% | ||
| Q1 25 | — | -251.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -482.0% | ||
| Q2 24 | — | -438.9% | ||
| Q1 24 | — | -356.2% |
| Q4 25 | $-0.38 | $-0.15 | ||
| Q3 25 | — | $-0.14 | ||
| Q2 25 | — | $-0.14 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | $-0.16 | ||
| Q3 24 | — | $-0.13 | ||
| Q2 24 | — | $-0.13 | ||
| Q1 24 | — | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.7M | $250.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $80.0M | $415.7M |
| Total Assets | $140.4M | $455.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.7M | $250.8M | ||
| Q3 25 | — | $251.2M | ||
| Q2 25 | — | $230.9M | ||
| Q1 25 | — | $240.9M | ||
| Q4 24 | — | $118.2M | ||
| Q3 24 | — | $132.0M | ||
| Q2 24 | — | $140.5M | ||
| Q1 24 | — | $146.6M |
| Q4 25 | $80.0M | $415.7M | ||
| Q3 25 | — | $381.2M | ||
| Q2 25 | — | $370.6M | ||
| Q1 25 | — | $397.1M | ||
| Q4 24 | — | $410.3M | ||
| Q3 24 | — | $439.4M | ||
| Q2 24 | — | $456.8M | ||
| Q1 24 | — | $479.4M |
| Q4 25 | $140.4M | $455.1M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $398.0M | ||
| Q1 25 | — | $419.4M | ||
| Q4 24 | — | $448.3M | ||
| Q3 24 | — | $470.9M | ||
| Q2 24 | — | $492.6M | ||
| Q1 24 | — | $516.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.0M | $-18.4M |
| Free Cash FlowOCF − Capex | — | $-23.0M |
| FCF MarginFCF / Revenue | — | -633.0% |
| Capex IntensityCapex / Revenue | — | 126.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-83.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-13.0M | $-18.4M | ||
| Q3 25 | — | $-14.3M | ||
| Q2 25 | — | $-14.4M | ||
| Q1 25 | — | $-26.3M | ||
| Q4 24 | — | $-13.9M | ||
| Q3 24 | — | $-9.9M | ||
| Q2 24 | — | $-11.1M | ||
| Q1 24 | — | $-29.1M |
| Q4 25 | — | $-23.0M | ||
| Q3 25 | — | $-14.8M | ||
| Q2 25 | — | $-17.1M | ||
| Q1 25 | — | $-28.6M | ||
| Q4 24 | — | $-18.6M | ||
| Q3 24 | — | $-12.6M | ||
| Q2 24 | — | $-15.5M | ||
| Q1 24 | — | $-33.1M |
| Q4 25 | — | -633.0% | ||
| Q3 25 | — | -397.6% | ||
| Q2 25 | — | -264.2% | ||
| Q1 25 | — | -476.1% | ||
| Q4 24 | — | -416.5% | ||
| Q3 24 | — | -271.5% | ||
| Q2 24 | — | -305.8% | ||
| Q1 24 | — | -556.3% |
| Q4 25 | — | 126.5% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | 41.5% | ||
| Q1 25 | — | 39.1% | ||
| Q4 24 | — | 105.5% | ||
| Q3 24 | — | 59.7% | ||
| Q2 24 | — | 86.8% | ||
| Q1 24 | — | 68.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
